Page 775 - Hall et al (2015) Principles of Critical Care-McGraw-Hill
P. 775

4       References


                      96. Brochard L, Isabey D, Piquet J, et al. Reversal of acute exac-    112. Aubier  M, Murciano D, Milic-Emili  J, et  al.  Effects  of the
                        erbations of chronic obstructive lung disease by inspiratory     administration of O2 on ventilation and blood gases in patients
                          assistance with a face mask. N Engl J Med. 1990;323:1523-1530.  with chronic obstructive pulmonary disease during acute respi-
                      97. Zhu GF, Zhang W, Zong H, et al. Effectiveness and safety of   ratory failure. Am Rev Respir Dis. 1980;122:747-754.
                        noninvasive positive-pressure ventilation for severe hypercapnic     113. Sassoon CS, Hassell KT, Mahutte CK. Hyperoxic-induced
                        encephalopathy due to acute exacerbation of chronic obstruc-  hypercapnia  in  stable  chronic  obstructive  pulmonary  disease.
                        tive pulmonary disease: a prospective case-control study. Chin   Am Rev Respir Dis. 1987;135:907-911.
                        Med J (Engl). 2007;120:2204-2209.                    114. Erbland ML, Ebert RV, Snow SL. Interaction of hypoxia and
                      98. Liesching T, Kwok H, Hill NS. Acute applications of noninvasive   hypercapnia on respiratory drive in patients with COPD. Chest.
                        positive pressure ventilation. Chest. 2003;124:699-713.  1990;97:1289-1294.
                      99. Anton A, Tarrega J, Giner J, et al. Acute physiologic effects of     115. Wagner PD, Dantzker DR, Dueck R, et al. Ventilation-perfusion
                        nasal and full-face masks during noninvasive positive-pressure   inequality in chronic obstructive pulmonary disease.  J Clin
                        ventilation in patients with acute exacerbations of chronic   Invest. 1977;59:203-216.
                        obstructive pulmonary disease. Respir Care. 2003;48:922-925.    116. Derenne JP, Fleury B, Pariente R. Acute respiratory failure of
                      100. Hill  NS.  Noninvasive  ventilation  for  chronic  obstructive   chronic obstructive pulmonary disease.  Am Rev Respir  Dis.
                          pulmonary disease. Respir Care. 2004;49:72-87; discussion 87-79.  1988;138:1006-1033.
                      101. Plant PK, Owen JL, Elliott MW. Early use of non-invasive venti-    117. Gomersall CD, Joynt GM, Freebairn RC, et al. Oxygen therapy
                        lation for acute exacerbations of chronic obstructive pulmonary   for hypercapnic patients with chronic obstructive pulmonary
                        disease on general respiratory wards: a multicentre randomised   disease and acute respiratory failure: a randomized, controlled
                        controlled trial. Lancet. 2000;355:1931-1935.           pilot study. Crit Care Med. 2002;30:113-116.
                      102. Appendini L, Purro A, Patessio A, et al. Partitioning of inspi-    118. Agusti AG, Carrera M, Barbe F, et al. Oxygen therapy during
                        ratory muscle workload and pressure assistance in ventilator-   exacerbations  of  chronic  obstructive  pulmonary  disease.  Eur
                        dependent COPD  patients.  Am J Respir Crit Care Med.   Respir J. 1999;14:934-939.
                        1996;154:1301-1309.                                  119. Moloney ED, Kiely JL, McNicholas WT. Controlled oxygen
                      103. Appendini L, Purro A, Gudjonsdottir M, et al. Physiologic   therapy and carbon dioxide retention during exacerbations
                        response of ventilator-dependent patients with chronic obstruc-  of chronic obstructive pulmonary disease.  Lancet. 2001;357:
                        tive pulmonary disease to proportional assist ventilation and   526-528.
                        continuous positive airway pressure. Am J Respir Crit Care Med.     120. Dunn WF, Nelson SB, Hubmayr RD. Oxygen-induced
                        1999;159:1510-1517.                                       hypercarbia in obstructive pulmonary disease. Am Rev Respir
                      104. Appendini L, Patessio A, Zanaboni S, et al. Physiologic effects   Dis. 1991;144:526-530.
                        of positive end-expiratory pressure and mask pressure support
                        during exacerbations of chronic obstructive pulmonary disease.     121. Schmidt GA, Hall JB. Oxygen therapy and hypoxic drive to
                        Am J Respir Crit Care Med. 1994;149:1069-1076.          breathe: is there danger in the patient with COPD? Intensive Crit
                                                                                Care Dig. 1989;8:124.
                      105. de Lucas P, Tarancon C, Puente L, et al. Nasal continuous posi-
                        tive airway pressure in patients with COPD in acute respiratory     122. Austin MA, Wills KE, Blizzard L, et al. Effect of high flow
                        failure. A study of the immediate effects.  Chest. 1993;104:   oxygen on mortality in chronic obstructive pulmonary disease
                        1694-1697.                                              patients  in  prehospital  setting:  randomised  controlled  trial.
                                                                                BMJ. 2010;341:c5462.
                      106. Miro AM, Shivaram U, Hertig I. Continuous positive airway
                        pressure in COPD patients in acute hypercapnic respiratory     123. Grootendorst DC, Rabe KF. Mechanisms of bronchial hyperre-
                        failure. Chest. 1993;103:266-268.                       activity in asthma and chronic obstructive pulmonary disease.
                                                                                Proc Am Thorac Soc. 2004;1:77-87.
                      107. Maggiore  SM,  Richard JC,  Abroug  F,  et  al.  A  multicenter,
                          randomized trial of noninvasive ventilation with helium-oxygen     124. Thomas P, Pugsley JA, Stewart JH. Theophylline and salbuta-
                        mixture in exacerbations of chronic obstructive lung disease.   mol improve pulmonary function in patients with   irreversible
                        Crit Care Med. 2010;38:145-151.                         chronic obstructive pulmonary disease. Chest. 1992;101:160-165.
                      108. Nava S, Ceriana P. Causes of failure of noninvasive mechanical     125. Petty TL. The combination of ipratropium and albuterol is more
                        ventilation. Respir Care. 2004;49:295-303.              effective than either agent alone. Chest. 1995;107:183S-186S.
                      109. Sinuff T, Kahnamoui K, Cook DJ, et al. Practice guidelines     126. McCrory DC, Brown CD. Anti-cholinergic bronchodilators
                        as multipurpose tools: a qualitative study of noninvasive   versus beta2-sympathomimetic agents for acute exacerbations
                          ventilation. Crit Care Med. 2007;35:776-782.          of chronic obstructive pulmonary disease. Cochrane Database
                      110. Global Initiative for Chronic Obstructive Lung Disease (GOLD).   Syst Rev. 2002:CD003900.
                        Global Strategy for Diagnosis, Management, and Prevention of     127. Pourriat JL, Baud M, Lamberto C, et al. Effects of doxapram on
                        COPD, (Updated 2009). Medical Communications Resources,   hypercapnic response during weaning from mechanical ventila-
                        Inc [Electronic]. 2009.  http://www.goldcopd.com/download.  tion in COPD patients. Chest. 1992;101:1639-1643.
                        asp?intId=554. Accessed November 22, 2010.           128. Greenstone M, Lasserson TJ. Doxapram for ventilatory failure
                      111. Crossley DJ, McGuire GP, Barrow PM, et al. Influence of   due to exacerbations of chronic obstructive pulmonary disease.
                        inspired oxygen concentration on deadspace, respiratory drive,   Cochrane Database Syst Rev. 2003:CD000223.
                        and PaCO  in intubated patients with chronic obstructive     129. Angus RM, Ahmed AA, Fenwick LJ, et al. Comparison of the
                                2
                          pulmonary disease. Crit Care Med. 1997;25:1522-1526.  acute effects on gas exchange of nasal ventilation and doxapram









              Section04-O-ref.indd   4                                                                                   1/21/2015   11:23:20 AM
   770   771   772   773   774   775   776   777   778   779   780